More articles from ENDOCRINE AND DIABETES

You have access
The Sodium Glucose Cotransporter Type 2 Inhibitor Empagliflozin Preserves β-Cell Mass and Restores Glucose Homeostasis in the Male Zucker Diabetic Fatty Rat
Henrik H. Hansen, Jacob Jelsing, Carl Frederik Hansen, Gitte Hansen, Niels Vrang, Michael Mark, Thomas Klein and Eric Mayoux

Journal of Pharmacology and Experimental Therapeutics September 2014, 350 (3) 657-664; DOI: https://doi.org/10.1124/jpet.114.213454
You have access
Maternal-Fetal Disposition of Glyburide in Pregnant Mice Is Dependent on Gestational Age
Diana L. Shuster, Linda J. Risler, Chao-Kang J. Liang, Kenneth M. Rice, Danny D. Shen, Mary F. Hebert, Kenneth E. Thummel and Qingcheng Mao

Journal of Pharmacology and Experimental Therapeutics August 2014, 350 (2) 425-434; DOI: https://doi.org/10.1124/jpet.114.213470
You have access
The Novel GLP-1–Gastrin Dual Agonist ZP3022 Improves Glucose Homeostasis and Increases β-Cell Mass without Affecting Islet Number in db/db Mice
Louise S. Dalbøge, Dorthe L. C. Almholt, Trine S. R. Neerup, Niels Vrang, Jacob Jelsing and Keld Fosgerau

Journal of Pharmacology and Experimental Therapeutics August 2014, 350 (2) 353-360; DOI: https://doi.org/10.1124/jpet.114.215293
You have access
Effect of LX4211 on Glucose Homeostasis and Body Composition in Preclinical Models
David R. Powell, Christopher M. DaCosta, Melinda Smith, Deon Doree, Angela Harris, Lindsey Buhring, William Heydorn, Amr Nouraldeen, Wendy Xiong, Padmaja Yalamanchili, Faika Mseeh, Alan Wilson, Melanie Shadoan, Brian Zambrowicz and Zhi-Ming Ding

Journal of Pharmacology and Experimental Therapeutics August 2014, 350 (2) 232-242; DOI: https://doi.org/10.1124/jpet.114.214304
You have access
Treatment with the 3-Ketoacyl-CoA Thiolase Inhibitor Trimetazidine Does Not Exacerbate Whole-Body Insulin Resistance in Obese Mice
John R. Ussher, Wendy Keung, Natasha Fillmore, Timothy R. Koves, Jun Mori, Liyan Zhang, David G. Lopaschuk, Olga R. Ilkayeva, Cory S. Wagg, Jagdip S. Jaswal, Deborah M. Muoio and Gary D. Lopaschuk

Journal of Pharmacology and Experimental Therapeutics June 2014, 349 (3) 487-496; DOI: https://doi.org/10.1124/jpet.114.214197
You have access
Pharmacological Evaluation of Adipose Dysfunction via 11β-Hydroxysteroid Dehydrogenase Type 1 in the Development of Diabetes in Diet-Induced Obese Mice with Cortisone Pellet Implantation
Nobuteru Akiyama, Yuko Akiyama, Hideaki Kato, Takayuki Kuroda, Takashi Ono, Keiichi Imagawa, Kenji Asakura, Toshihiro Shinosaki, Toshihiko Murayama and Kohji Hanasaki

Journal of Pharmacology and Experimental Therapeutics April 2014, 349 (1) 66-74; DOI: https://doi.org/10.1124/jpet.113.210716
You have access
Chronic Treatment with Novel GPR40 Agonists Improve Whole-Body Glucose Metabolism Based on the Glucose-Dependent Insulin Secretion
Hirotsugu Tanaka, Shigeru Yoshida, Hiroyuki Oshima, Hideaki Minoura, Kenji Negoro, Takao Yamazaki, Shuichi Sakuda, Fumiyoshi Iwasaki, Tetsuo Matsui and Masayuki Shibasaki

Journal of Pharmacology and Experimental Therapeutics September 2013, 346 (3) 443-452; DOI: https://doi.org/10.1124/jpet.113.206466
You have access
Development of a Novel Long-Acting Antidiabetic FGF21 Mimetic by Targeted Conjugation to a Scaffold Antibody
Jie Huang, Tetsuya Ishino, Gang Chen, Paul Rolzin, Trina F. Osothprarop, Kelsey Retting, Lingna Li, Ping Jin, Marla J. Matin, Bernard Huyghe, Saswata Talukdar, Curt W. Bradshaw, Moorthy Palanki, Bernard N. Violand, Gary Woodnutt, Rodney W. Lappe, Kathleen Ogilvie and Nancy Levin

Journal of Pharmacology and Experimental Therapeutics August 2013, 346 (2) 270-280; DOI: https://doi.org/10.1124/jpet.113.204420
You have access
Neuroprotective Effects of Cilostazol on Retinal Ganglion Cell Damage in Diabetic Rats
Kyoung In Jung, Jie Hyun Kim, Hae-Young Lopilly Park and Chan Kee Park

Journal of Pharmacology and Experimental Therapeutics June 2013, 345 (3) 457-463; DOI: https://doi.org/10.1124/jpet.113.203067
You have access
LX4211 Increases Serum Glucagon-Like Peptide 1 and Peptide YY Levels by Reducing Sodium/Glucose Cotransporter 1 (SGLT1)–Mediated Absorption of Intestinal Glucose
David R. Powell, Melinda Smith, Jennifer Greer, Angela Harris, Sharon Zhao, Christopher DaCosta, Faika Mseeh, Melanie K. Shadoan, Arthur Sands, Brian Zambrowicz and Zhi-Ming Ding

Journal of Pharmacology and Experimental Therapeutics May 2013, 345 (2) 250-259; DOI: https://doi.org/10.1124/jpet.113.203364

Main menu

User menu

Search

More articles from ENDOCRINE AND DIABETES

Pages

Navigate

More Information

ASPET's Other Journals